Management of inflammaging in kidney diseases: focusing on the current investigational drugs

No Thumbnail Available

Date

2024-10

Journal Title

Journal ISSN

Volume Title

Publisher

Taylor & Francis

Abstract

To improve kidney disease treatments, it is crucial to understand how inflammaging affects patients´ longevity. We could potentially slow down kidney disease progression and enhance longevity by targeting specific pathways involved in inflammaging with potential drugs.

Description

Keywords

Pharmacy, Autophagy, Caloric restriction, Inflammaging, Kidney diseases, Metabolic dysregulation

Citation

Endorsement

Review

Supplemented By

Referenced By